Clinical Trial Update: Assessing Durable Antibody Response to HPV Vaccination [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the durability of antibody responses after HPV vaccination, with results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: Emory University | Conditions: HPV | Phase 4 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-10-23